Iterum Therapeutics plc — Director's Dealing 2019

May 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2019-05-24

Reporting Person: Edick Paul R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-24	Ordinary Shares	M	6154	—	Acquired	31390	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-24	Restricted Stock Units	$	M	6154	Disposed		Ordinary Shares (6154)	Direct

Footnotes

F1: Restricted stock units converted into ordinary shares on a one-for-one basis upon vesting of the units.

F2: On May 24, 2018, the reporting person was granted an award of 6,154 restricted stock units, which vested on May 24, 2019.